Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Sienna Biopharmaceuticals (SNNA) Stock

Press coverage about Sienna Biopharmaceuticals (NASDAQ:SNNA) has trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Sienna Biopharmaceuticals earned a daily sentiment score of 0.10 on Accern’s scale. Accern also assigned news articles about the company an impact score of 44.5945003731169 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Shares of Sienna Biopharmaceuticals traded down $0.11, reaching $15.80, during trading on Tuesday, MarketBeat reports. The company’s stock had a trading volume of 68,200 shares, compared to its average volume of 87,698. The stock has a market capitalization of $350.37 million and a price-to-earnings ratio of -3.04. Sienna Biopharmaceuticals has a 1-year low of $13.37 and a 1-year high of $29.25.

Get Sienna Biopharmaceuticals alerts:

Sienna Biopharmaceuticals (NASDAQ:SNNA) last posted its quarterly earnings data on Monday, May 14th. The company reported ($0.85) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.70) by ($0.15). equities research analysts forecast that Sienna Biopharmaceuticals will post -2.91 EPS for the current year.

A number of analysts have recently weighed in on the company. ValuEngine raised Sienna Biopharmaceuticals from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. Zacks Investment Research raised Sienna Biopharmaceuticals from a “sell” rating to a “hold” rating in a research report on Thursday, May 31st. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $32.25.

In other news, insider Todd Harris sold 18,011 shares of the firm’s stock in a transaction on Wednesday, April 18th. The stock was sold at an average price of $20.08, for a total value of $361,660.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders sold a total of 19,086 shares of company stock valued at $383,161 in the last three months. Insiders own 27.00% of the company’s stock.

About Sienna Biopharmaceuticals

Sienna Biopharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of topical products in medical dermatology and aesthetics. The company's lead product candidates include SNA-120, a first-in-class inhibitor of tropomyosin receptor kinase A, which is in a Phase IIb clinical trial for the treatment of pruritus or itch associated with psoriasis, as well as for psoriasis; and SNA-125, a topical janus kinase 3 inhibitor that is in Phase I/II clinical trials for the treatment of atopic dermatitis, psoriasis, and pruritus.

Read More: How Short Selling Works

Best High Tech Stocks To Watch For 2019

tags:SATS,PAGP,PETM,

As stocks rallied following last week's election, Apple (APPL) , Amazon (AMZN) , Alphabet (GOOGL) and Facebook (FB) bucked the positive stock market momentum and now have negative weekly chart profiles.

Each ended last week below the key weekly moving averages, with weekly momentum readings declining below the overbought threshold of 80.00. Closes this week below $111.00 on Apple, $772.92 on Amazon, $792.05 on Alphabet, and $123.60 on Facebook will keep the weekly charts negative.

Facebook and Alphabet are holdings in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio. Want to be alerted before Cramer buys or sells FB or GOOGL? Learn more now.

On Nov. 4, the weekly charts were flashing warnings that these four benchmark momentum stocks were losing their mojo. This makes it extremely important to focus on daily charts, using Fibonacci retracements and key trading levels from my proprietary analytics.

Best High Tech Stocks To Watch For 2019: EchoStar Corporation(SATS)

Advisors' Opinion:

• [By Max Byerly]

  Teachers Advisors LLC grew its stake in shares of Echostar Co. (NASDAQ:SATS) by 9.2% in the fourth quarter, Holdings Channel reports. The fund owned 59,929 shares of the communications equipment provider’s stock after buying an additional 5,059 shares during the quarter. Teachers Advisors LLC’s holdings in Echostar were worth $3,590,000 at the end of the most recent reporting period.

• [By Lisa Levin] Companies Reporting Before The Bell Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million. AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million. Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion. Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion. Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion. Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion. Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million. Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million. ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million. Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion. Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion. Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion. NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million. World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million. MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million. Choice Hotels International, Inc. (NYSE: CH
• [By Shane Hupp]

  Echostar Holding Corp (NASDAQ:SATS) reached a new 52-week high and low during mid-day trading on Friday . The company traded as low as $51.33 and last traded at $52.44, with a volume of 104714 shares trading hands. The stock had previously closed at $51.79.

Best High Tech Stocks To Watch For 2019: Plains Group Holdings, L.P.(PAGP)

Advisors' Opinion:

• [By Lisa Levin]

   

  Companies Reporting After The Bell Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion. Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion. The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion. Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million. Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion. LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion. Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion. TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million. The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million. A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion. Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million. Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million. ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million. KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13
• [By Stephan Byrd]

  TheStreet upgraded shares of Plains GP (NYSE:PAGP) from a d+ rating to a c- rating in a research report released on Monday morning.

  Several other analysts have also recently issued reports on the company. Stifel Nicolaus cut Plains GP from a buy rating to a hold rating and set a $24.00 price objective on the stock. in a report on Wednesday. Jefferies Group cut Plains GP from a buy rating to a hold rating in a report on Wednesday, April 25th. Wolfe Research cut Plains GP from a market perform rating to an underperform rating in a report on Tuesday, April 24th. Deutsche Bank began coverage on Plains GP in a report on Thursday, April 19th. They set a buy rating and a $29.00 price objective on the stock. Finally, SunTrust Banks raised Plains GP from a hold rating to a buy rating and set a $27.00 price objective on the stock in a report on Monday, April 9th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $25.65.

• [By Shane Hupp]

  News coverage about Plains GP (NYSE:PAGP) has been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Plains GP earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the pipeline company an impact score of 46.0549967457103 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Best High Tech Stocks To Watch For 2019: PetSmart Inc(PETM)

Advisors' Opinion:

• [By Joseph Griffin]

  An issue of PetSmart, Inc. (NASDAQ:PETM) bonds fell 1.6% as a percentage of their face value during trading on Wednesday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $49.19 and was trading at $55.47 one week ago. Price changes in a company’s bonds in credit markets often predict parallel changes in its stock price.

• [By Shane Hupp]

  An issue of PetSmart, Inc. (NASDAQ:PETM) debt rose 1% against its face value during trading on Monday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $67.50 and was trading at $66.25 last week. Price moves in a company’s debt in credit markets often anticipate parallel moves in its share price.

Eaton Vance Tax Managed Buy Write Opport (ETV) Hits New 1-Year High at $15.69

Shares of Eaton Vance Tax Managed Buy Write Opport (NYSE:ETV) reached a new 52-week high on Thursday . The company traded as high as $15.69 and last traded at $15.68, with a volume of 1769 shares. The stock had previously closed at $15.64.

Get Eaton Vance Tax Managed Buy Write Opport alerts:

The company also recently announced a monthly dividend, which will be paid on Tuesday, July 31st. Stockholders of record on Tuesday, July 24th will be issued a dividend of $0.111 per share. This is a positive change from Eaton Vance Tax Managed Buy Write Opport’s previous monthly dividend of $0.11. This represents a $1.33 dividend on an annualized basis and a dividend yield of 8.49%. The ex-dividend date of this dividend is Monday, July 23rd.

In other news, insider Jeffrey P. Beale sold 29,389 shares of the stock in a transaction dated Friday, May 4th. The shares were sold at an average price of $8.54, for a total transaction of $250,982.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Several institutional investors have recently bought and sold shares of ETV. Csenge Advisory Group purchased a new stake in shares of Eaton Vance Tax Managed Buy Write Opport during the first quarter worth about $153,000. Palladium Partners LLC purchased a new stake in shares of Eaton Vance Tax Managed Buy Write Opport during the first quarter worth about $191,000. Dynamic Advisor Solutions LLC purchased a new stake in shares of Eaton Vance Tax Managed Buy Write Opport during the first quarter worth about $208,000. Wealth Alliance Advisory Group LLC purchased a new stake in Eaton Vance Tax Managed Buy Write Opport in the first quarter worth about $218,000. Finally, BB&T Securities LLC purchased a new stake in Eaton Vance Tax Managed Buy Write Opport in the first quarter worth about $259,000.

About Eaton Vance Tax Managed Buy Write Opport

There is no company description available for Eaton Vance Tax-Managed Buy-Write Opportunities Fund.

Best Undervalued Stocks To Own For 2019

tags:COO,LAYN,PDCO,USPH,TRIP,

I will review why this helps Net1 UEPS Technologies (UEPS) and cryptocurrencies. I will also review why Net1 UEPS Technologies is undervalued and overlooked.

Stocks that have been affected by the cryptocurrency expansion have seen major rallies. For example, Nvidia (NVDA), 1,000% in 30 months; Advanced Micro Devices (AMD), 500% in 21 months; and Overstock.com (OSTK), 333% in 6 months. I do not think Net1 will profit as much as the above stocks, but I am certain that the company will benefit from this recent partnership.

Masterpayment and Bitstamp

Bitstamp is the second largest cryptocurrency trading platform in the world. Bitstamp is the largest Bitcoin exchange in the EU in terms of volume. It holds the world's second largest market share (22%) for bitcoin transactions based on a weighted order book. It is ranked number two for bitcoin exchanges based on numerous factors, including volume, spread, volatility, trades per minute, etc. It also trades Litecoin, Ether, and Ripple.

Best Undervalued Stocks To Own For 2019: Cooper Companies, Inc. (COO)

Advisors' Opinion:

• [By Stephan Byrd]

  The Cooper Companies (NYSE:COO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Cooper Companies has recently acquired the assets of The LifeGlobal Group and its affiliates, bolstering its foothold in the in-vitro fertilization (IVF) devices market. Meanwhile, the CooperVision business has been delivering impressive results. A raised guidance for fiscal 2018 looks promising. Notably, Cooper Companies completed the acquisition of Paragon Vision Sciences. This added a leading ortho-k technology to the company’s lens portfolio. Considering the outstanding performance of the stock, we expect Cooper Companies to scale higher in the coming quarters. On the flipside, intense competition in the contact lens space will continue to build pricing pressure. Additionally, escalating debt levels and foreign exchange vulnerability are likely to mar the company’s bottom line. Also, the slashed revenue guidance for fiscal 2018 in CSI segment is discouraging. Cooper has underperformed its industry in a year’s time.”

• [By Motley Fool Staff]

  The Cooper Companies, Inc. (NYSE:COO)Q2 2018 Earnings Conference CallMay 7, 2018, 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Garrett Baldwin]
  Goldman Sachs Group Inc. (NYSE: GS) chief economist Jan Hatzius has a message for the markets. Hatzius said in a research note on Monday that U.S. GDP has likely peaked. "The current pace is probably as good as it gets because we expect the impulse from financial conditions to gradually turn more negative," Hatzius said. The European Union slapped America with roughly $3.3 billion in tariffs on U.S. goods. The tariffs, which are in retaliation to the Trump administration's recent steel and aluminum tariffs on the EU, will go into effect in July. They specifically target products like cigarettes, whiskey, denim, and orange juice. Stocks to Watch Today: AVGO, AGN, GOOGL, TSLA Broadcom Ltd.�(Nasdaq: AVGO) leads a busy day of earnings reports. Wall Street anticipates the firm will report earnings per share of $4.77 on top of $5.00 billion in revenue. Uncertainty still remains on whether the company will be able to purchase industry rival Qualcomm Inc.�(Nasdaq: QCOM) in a deal that would be the largest technology merger in the history of the markets. Shares of Alphabet Inc. (Nasdaq: GOOGL) are under pressure due to more regulatory scrutiny by the European Union. Shares were off slightly this morning as investors digested a report from The Financial Times indicating the EU will hit the firm with a antitrust fine. Tesla Inc. (Nasdaq: TSLA) stock popped nearly 10% Wednesday, crushing short sellers of the stock. Investors betting against the stock lost a collective $1 billion on paper yesterday, according to S3 Partners. This week, founder Elon Musk won a battle to maintain his roles as both CEO and chair. He also provided a boost of optimism to TSLA stock over production expectations for the Model 3 vehicle. Allergan Inc. (NYSE: AGN) shares are up 2.4% thanks to its latest activist investor. Billionaire investor Carl Icahn purchased a small stake in the drug maker at a time when other activist investors are pushing for strategic changes by the company.

Best Undervalued Stocks To Own For 2019: Layne Christensen Company(LAYN)

Advisors' Opinion:

• [By Ethan Ryder]

  Here are some of the news articles that may have impacted Accern’s rankings:

  Get Layne Christensen alerts: Critical Survey: Layne Christensen (LAYN) and Real Goods Solar (RGSE) (americanbankingnews.com) Glass Lewis joins ISS in supporting Layne Christensen buyout (seekingalpha.com) Glass Lewis Joins ISS in Recommending that Layne Christensen Stockholders Vote for the Proposed Merger with Granite (prnewswire.com) Net income boost as investors vote on Layne closure (globalwaterintel.com) Edited Transcript of LAYN earnings conference call or presentation 6-Jun-18 1:00pm GMT (finance.yahoo.com)

  LAYN stock traded down $0.17 during trading hours on Tuesday, hitting $15.58. The company’s stock had a trading volume of 16,668 shares, compared to its average volume of 247,366. The company has a quick ratio of 0.85, a current ratio of 0.99 and a debt-to-equity ratio of 1.67. The company has a market capitalization of $318.08 million, a price-to-earnings ratio of -21.64 and a beta of 0.50. Layne Christensen has a 12 month low of $8.19 and a 12 month high of $16.96.

• [By Logan Wallace]

  Headlines about Layne Christensen (NASDAQ:LAYN) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Layne Christensen earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave media coverage about the construction company an impact score of 45.8722865003839 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

• [By Stephan Byrd]

  Barclays PLC increased its holdings in shares of Layne Christensen (NASDAQ:LAYN) by 1,886.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,851 shares of the construction company’s stock after acquiring an additional 53,989 shares during the period. Barclays PLC’s holdings in Layne Christensen were worth $848,000 at the end of the most recent reporting period.

Best Undervalued Stocks To Own For 2019: Patterson Companies, Inc.(PDCO)

Advisors' Opinion:

• [By Logan Wallace]

  Gabelli Funds LLC lifted its stake in Patterson Companies (NASDAQ:PDCO) by 18.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 560,300 shares of the company’s stock after purchasing an additional 87,800 shares during the quarter. Gabelli Funds LLC owned 0.59% of Patterson Companies worth $12,455,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Patterson Companies (PDCO)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Patterson Companies (PDCO)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Brian Orelli]

  Shares of Patterson Companies (NASDAQ:PDCO) are up 4.4% at 12:45 p.m. EDT, having been up as much as 12.1%, after the dental and animal health company announced�results of its fourth fiscal quarter that ended on April 28.

• [By Joseph Griffin]

  Element Capital Management LLC acquired a new stake in Patterson Companies, Inc. (NASDAQ:PDCO) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 51,030 shares of the company’s stock, valued at approximately $1,134,000. Element Capital Management LLC owned about 0.05% of Patterson Companies as of its most recent filing with the SEC.

• [By Motley Fool Staff]

  Patterson Companies (NASDAQ:PDCO) Q4 2018 Earnings Conference CallJun. 21, 2018 10:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Best Undervalued Stocks To Own For 2019: U.S. Physical Therapy, Inc.(USPH)

Advisors' Opinion:

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Undervalued Stocks To Own For 2019: TripAdvisor, Inc.(TRIP)

Advisors' Opinion:

• [By Dan Caplinger]

  TripAdvisor (NASDAQ:TRIP) has been working hard for a long time to establish itself as a giant in the online travel business, and immense competition has made this task a tough one to accomplish. Having sought to make a transition from focusing on gathering reviews and other travel-related information to instead offering direct booking services, TripAdvisor has to walk a fine line to keep its reputation intact while expanding to become more profitable.

• [By Motley Fool Staff]

  Meanwhile, both TripAdvisor (NASDAQ:TRIP) and Booking Holdings (NASDAQ:BKNG) reported better-than-expected Q1 earnings, but only one of the online travel agencies got a stock uptick. The Fools explain why, and talk about the investment theses for them.

• [By Rich Smith]

  Shares of TripAdvisor (NASDAQ:TRIP)�are in a funk.

  Particularly strong in hotel and destination reviews, TripAdvisor remains the most popular travel-related website in the United States by search traffic, scoring an average of 35 million site visits per month last year. But you wouldn't know it from the stock price.

• [By Logan Wallace]

  Shares of Tripadvisor Inc Common Stock (NASDAQ:TRIP) have earned an average recommendation of “Hold” from the twenty-seven research firms that are covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a sell rating, nineteen have given a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $41.28.

• [By Demitrios Kalogeropoulos]

  There are many reasons an investor might be attracted to TripAdvisor (NASDAQ:TRIP) stock. It boasts an enviable position in the online hotel booking space, after all, and the travel specialist is cultivating new business lines that might soon become significant revenue streams in their own rights.

• [By ]

  I'm talking about returns of 31%, 35%, and more -- all in a matter of weeks rather than months or years. In fact, we just closed a trade on TripAdvisor (Nasdaq: TRIP) for a clean 26.3% in just ten days.

Gig Economy Fails to Equalize Gender Pay Gap

The gig economy was supposed to deliver a variety of benefits. Workers could work when and as much as they wanted while maintaining a work-life balance that made them happy. Would that it were so.

Economist Laurence Michel published a study in May that looked at the ride-sharing service Uber and concluded that the company’s drivers were earning less than $12 an hour after commissions, booking fees and expenses.

A new study by economists at Stanford and the University of Chicago shows that the gig economy has even failed to eliminate the pay gap between men and women, based on a study of Uber workers. Women who drive for Uber earn 7% less per hour than men.

The study’s authors show that the gap “can be entirely attributed to three factors”:

Experience on the platform (learning-by-doing)

Preferences over where to work (driven largely by where workers live and, to a lesser extent, safety)

Preferences for driving speed.

Almost half the difference in pay was due to the fact that men simply drive faster than women. Men are also more likely to have been on the job longer and are more willing to drive in areas with high crime rates than are women. The researchers’ conclusion:

[T]here is no reason to expect the “gig” economy to close gender differences. Even in the absence of discrimination and in flexible labor markets, women’s relatively high opportunity cost of non-paid-work time and gender-based differences in preferences and constraints can sustain a gender pay gap.

The study’s findings line up with earlier studies of gender pay inequality that show self-employed women make about 15% less than men and women who are independent contractors earn 21.5% less than men. The gig economy may be better, but it’s not yet equal.

24/7 Wall St.
Merrill Lynch Issues Top 8 US Stock Ideas for Q3 2018

In Your 60s? 3 Things to Know About Social Security

Many people don't bother concerning themselves with Social Security until filing for it becomes a reality. But if you're in your 60s, those benefits might come into play sooner than expected. Here are a few things all older workers should know about Social Security -- especially during what could end up being the most pivotal decade of your career.

1. You may be coming up on your full retirement age

Though you're allowed to file for Social Security as early as age 62, many workers choose to hold off on benefits until their full retirement age (FRA) rolls around. This way, they get to collect the full monthly benefit their work history entitles them to without having to worry about facing a reduction for filing early. That said, your FRA could be just around the corner, depending on your year of birth.

IMAGE SOURCE: GETTY IMAGES.

If you were born in 1954 or earlier, your full retirement age is 66. FRA then increases slightly for those born later, as follows:

Year of Birth

Full Retirement Age

1943-1954	66
1955	66 and 2 months
1956	66 and 4 months
1957	66 and 6 months
1958	66 and 8 months
1959	66 and 10 months
1960	67

DATA SOURCE: SOCIAL SECURITY ADMINISTRATION.

Pay attention to your FRA, and develop a filing strategy around that age. This doesn't mean that you should file at your precise full retirement age -- rather, figure out when that age is and determine the best time to start taking benefits in relation to it.

2. You can only delay your benefits for so long

Filing for Social Security at FRA is a good way to ensure that you get your full monthly benefit. At the same time, if you delay benefits past FRA, you'll snag an 8% boost on those payments for each year you hold off.

But don't make plans to delay those benefits indefinitely. Once you turn 70, you can no longer accrue delayed retirement credits that increase your monthly payments, so if you're in your late 60s and haven't yet filed for Social Security, mark your calendar to do so in conjunction with your 70th�birthday.

3. Working longer could boost your benefits

Though the age at which you first file for Social Security can impact your monthly benefits, those payments themselves are calculated based on how much you earned during your top 35 working years. Therefore, if you're eager to boost your benefits in time for retirement, working a bit longer could achieve that key goal.

Imagine you're 66 and are ready to take benefits at full retirement age, but your work record is limited to 33 years. This means that you'll have $0 factored in for two out of 35 years in the formula that establishes your full benefit amount, thereby lowering that number. On the other hand, if you work two extra years and replace those two zeros with an actual salary, your personal formula will change and your monthly benefits will go up.

The same holds true if you're making far more money in your 60s than you were earlier in life. If you're able to replace two years of $25,000 in earnings with two years of $125,000 in earnings, your monthly benefits stand to climb as well.

Your 60s are the perfect time to get serious about Social Security, so even if you're not planning or able to file just yet, it pays to read up on how the program works. The more you learn about Social Security, the better positioned you'll be to make the most of your benefits, no matter when you actually claim them.

Why women need mid-career mentors

You probably have a mental picture of the usual mentor-mentee relationship: a college-aged ingenue sitting at lunch with an industry veteran.

But for some women, that picture isn't accurate. For an older woman looking for mentorship through a career transition, creative stagnation or the second half of her career, there are increasingly few places to turn: there's no alumni network or old boys' club to step in and help.

That's a problem for both women and employers since sponsorship and mentorship can be key to retaining female talent.

Where can women turn if they're looking for guidance at later stages of their career?

Part of it is subverting our ideas of what mentorship looks like, says Nilanjana Dasgupta, professor of psychology at the University of Massachusetts.

"Mentoring doesn't always happen in a hierarchical way," she says. "Often, mentoring happens in bidirectional ways, and you learn different things from different people."

Particularly for senior women, finding mentors who look like them can be a challenge. For women of color, they feel a dual pressure of wanting to advance in their own careers even as they spend significant time shepherding younger people of color through the ranks, says Laura Sherbin, co-president at the Center for Talent Innovation.

"Everybody looks above them in the company and thinks 'The people who made it there, they figured things out,'" she says. "What's really hard to see when you look at somebody more senior than you �� this is even true for the CEOs �� they're still proving themselves. They're still proving they're not a diversity hire. They're still proving they got the goods. This need to prove yourself never actually goes away."

Mutual mentoring or peer networks are another good source of inspiration for women in leadership. Some programs even pair executive mentees with junior mentors, where the younger employee shares different skills or experiences with the senior worker.

When Boston architect Emily Papparelle first joined a mid-career women's mentoring group, she says she felt "a little embarrassed" to be applying for a mentor nearly 10 years into her career. But after she met her mentor and connected with the other women in the group, her perspective changed entirely.

"I had gotten 10 years into my career and never really had a mentor, let alone a female mentor," she says. "I learned we do still need mentors 10 years into careers. It's not too late. You have been in the same place for 10 years and you start to not really know your place. And someone else says 'No, I have seen your portfolio. I have gotten to know you. You are very valuable, here is your potential.'"

Zimmer Biomet (ZBH) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research lowered shares of Zimmer Biomet (NYSE:ZBH) from a hold rating to a sell rating in a report released on Monday morning.

According to Zacks, “In the past three months, Zimmer Biomet has been observed to underperform its industry. The year-over-year decline in earnings and revenues in the last reported quarter made investors jittery.  Declining sales at Knees, Hips and other segments at CER were a major disappointment. According to the company, slower pace of supply recovery and sales recapture related to major brands within the company’s Knee, Hip and S.E.T. segments marred the quarterly performance. Also, escalating costs and expenses impacted margins.  On the bright side, the company’s consistent efforts in product and renovation through research and development raise hopes. We are optimistic about synergies from the LDR buyout as well. We are also impressed by the strategic and financial goals which the combined entity expects to reach.”

Get Zimmer Biomet alerts:

A number of other equities research analysts have also recently commented on the company. ValuEngine cut Zimmer Biomet from a buy rating to a hold rating in a research note on Friday, March 23rd. Robert W. Baird cut Zimmer Biomet from an outperform rating to a neutral rating in a research note on Friday, March 23rd. Evercore ISI initiated coverage on Zimmer Biomet in a research note on Monday, April 2nd. They issued an in-line rating and a $115.00 price objective for the company. Morgan Stanley reduced their price objective on Zimmer Biomet from $148.00 to $140.00 and set an overweight rating for the company in a research note on Friday, April 27th. Finally, Raymond James initiated coverage on Zimmer Biomet in a research note on Thursday, March 15th. They issued an outperform rating and a $135.00 price objective for the company. Four analysts have rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of Buy and an average price target of $135.82.

Shares of Zimmer Biomet opened at $111.82 on Monday, MarketBeat.com reports. The company has a quick ratio of 1.07, a current ratio of 1.69 and a debt-to-equity ratio of 0.79. Zimmer Biomet has a 52 week low of $104.28 and a 52 week high of $133.49. The company has a market capitalization of $22.65 billion, a price-to-earnings ratio of 13.73, a PEG ratio of 2.18 and a beta of 1.13.

Zimmer Biomet (NYSE:ZBH) last announced its quarterly earnings data on Thursday, April 26th. The medical equipment provider reported $1.91 EPS for the quarter, beating the Zacks’ consensus estimate of $1.89 by $0.02. Zimmer Biomet had a return on equity of 14.36% and a net margin of 21.81%. The firm had revenue of $2.02 billion during the quarter, compared to analysts’ expectations of $1.98 billion. During the same quarter last year, the firm posted $2.13 earnings per share. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. research analysts predict that Zimmer Biomet will post 7.67 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 31st. Investors of record on Friday, June 29th will be issued a dividend of $0.24 per share. The ex-dividend date is Thursday, June 28th. This represents a $0.96 dividend on an annualized basis and a yield of 0.86%. Zimmer Biomet’s dividend payout ratio (DPR) is currently 11.96%.

In related news, insider Katarzyna Mazur-Hofsaess sold 8,765 shares of Zimmer Biomet stock in a transaction on Tuesday, May 22nd. The stock was sold at an average price of $113.61, for a total transaction of $995,791.65. Following the sale, the insider now directly owns 25,447 shares in the company, valued at $2,891,033.67. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Tony W. Collins sold 1,330 shares of Zimmer Biomet stock in a transaction on Monday, April 30th. The stock was sold at an average price of $116.73, for a total value of $155,250.90. The disclosure for this sale can be found here. Company insiders own 0.71% of the company’s stock.

A number of institutional investors have recently modified their holdings of ZBH. Bedel Financial Consulting Inc. bought a new stake in Zimmer Biomet during the first quarter worth $111,000. Summit Trail Advisors LLC lifted its holdings in Zimmer Biomet by 8,836.9% during the first quarter. Summit Trail Advisors LLC now owns 127,887 shares of the medical equipment provider’s stock worth $128,000 after acquiring an additional 126,456 shares during the period. Massey Quick Simon & CO. LLC lifted its holdings in Zimmer Biomet by 100.0% during the first quarter. Massey Quick Simon & CO. LLC now owns 1,200 shares of the medical equipment provider’s stock worth $131,000 after acquiring an additional 600 shares during the period. We Are One Seven LLC bought a new stake in Zimmer Biomet during the fourth quarter worth $137,000. Finally, Adviser Investments LLC bought a new stake in Zimmer Biomet during the first quarter worth $144,000. Institutional investors and hedge funds own 87.38% of the company’s stock.

Zimmer Biomet Company Profile

Zimmer Biomet Holdings, Inc, together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental.

Get a free copy of the Zacks research report on Zimmer Biomet (ZBH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com